$9.41 Billion Wearable Injectors Market by Type & Therapy – Global Forecast to 2023 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Wearable
Injectors Market by Type (On-Body and Off-Body injectors (Infusion Pump
Devices)), Therapy (Immuno-oncology, Diabetes, Cardiovascular Diseases,
Parkinson’s Disease, Thalassemia, Primary Immunodeficiency Disease) –
Global Forecast to 2023”
report has been added to ResearchAndMarkets.com’s
offering.

The global wearable injectors market is projected to reach USD 9.41
billion by 2023 from an estimated USD 5.57 billion in 2018, at a CAGR of
11.1% during the forecast period.

The growing prevalence of targeted therapies, favorable reimbursement,
and technological advancements in wearable injectors are expected to
drive the growth of the wearable injectors market. However, the
preference for alternative routes of drug delivery such as pens &
autoinjectors is expected to restrain the growth of this market to a
certain extent.

Based on type, the market is segmented into on-body and off-body
injectors. The off-body injectors segment is expected to register the
highest CAGR during the forecast period. The drawbacks associated with
on-body wearable injectors, such as painful removal, skin sensitivity
issues and irritation, and adhesive fitting issues have resulted in the
increased demand for off-body injectors.

Based on therapy, the global wearable injectors market is segmented into
immuno-oncology, diabetes, cardiovascular diseases, and other therapies
(Parkinson’s Disease, thalassemia, and primary immunodeficiency
disorders). The cardiovascular diseases segment is expected to witness
the highest CAGR during the forecast period. The high growth of the
segment can be primarily attributed to the high burden of CVDs across
the globe coupled with the growing availability of wearable injectors
for the treatment of CVDs.

North America is expected to witness the highest growth from 2018 to
2023. This can be attributed to the rising prevalence of chronic
diseases in the US and Canada; favorable reimbursement scenarios; and an
increasing number of awareness programs in the US and Canada.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Wearable Injectors Market Overview

6 Wearable Injectors Market By Type

7 Wearable Injectors Market By Therapy

8 Wearable Injectors Market By Region

9 Competitive Landscape

10 Company Profiles

  • Amgen
  • Becton, Dickinson and Company
  • Enable Injections
  • Insulet Corporation
  • Medtronic PLC
  • Sensile Medical (A Part of Gerresheimer)
  • Steadymed Therapeutics
  • Tandem Diabetes Care, Inc.
  • United Therapeutics Corporation
  • Valeritas, Inc.
  • Ypsomed

For more information about this report visit https://www.researchandmarkets.com/research/jtfc72/9_41_billion?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Infusions
and Injectables
, Needles
and Syringes

leverton

I have been involved with publishing and marketing for the past 32 years. My passion is helping people share their voice. I am able to do this through two important venues: One, with Area-Info.net where people can share everything from opinions to events to news. It is your choice! What do you want to share? Two, through a new program called America's Real Deal I am involved with to help business owners get their voice heard.I schedule speaking engagements with community groups and business groups to share my passion about the importance of "sharing your voice".Contact me directly at lee@leeeverton.com for scheduling information.